NASDAQ$AMED

Amedisys Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Amedisys's Q4 2023 financial results reflected a slight increase in net service revenue, offset by a decrease in net income due to merger-related expenses.

Amedisys reported a slight increase in net service revenue for Q4 2023, but net income was negatively impacted by merger-related costs. The company's adjusted EBITDA also saw a decrease compared to the previous year.

  • Net service revenue increased to $570.8 million from $562.0 million in Q4 2022.
  • Net income attributable to Amedisys, Inc. was $19.3 million, compared to $31.7 million in Q4 2022, impacted by $11.5 million in merger transaction costs.
  • Adjusted EBITDA decreased to $56.7 million from $59.9 million in the prior year.
  • Adjusted net income attributable to Amedisys, Inc. was $30.8 million, compared to $38.0 million in 2022.

Headline financials

Total Revenue

$571M

Previous: $562M+1.6%
EPS (adj)

$0.94

Previous: $1.16-19.0%
Capital Expenditures

-$2.1M

Previous: $1.83M-215.2%
Net Income

$19M

Previous: $31.5M-39.7%
Operating Income

$34M

Previous: $46.2M-26.4%
Gross Profit

$430M

Previous: $245M+75.7%
Stock-Based Comp

$9.4M

Previous: $570K+1549.1%

Revenue & EPS history

Amedisys · Revenue · Quarterly

$571M

Q4 2023+1.6%vs Q4 2022
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Forward guidance

Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year ended December 31, 2023 results in light of the pending merger of the Company with UnitedHealth Group Incorporated.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 15 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-5.0%

Avg return

30 days after

46%

32 / 70 earnings

Positive

+25.6%

Q2 2014

Best reaction

-25.3%

Q3 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025
Q2 2025+1.2%+1.0%
Q1 2025+0.2%-0.8%-1.6%
Q4 2024+0.1%+0.6%+1.5%
Q3 2024+0.9%-3.4%-10.4%
Q2 2024+0.0%+0.5%-0.2%
Q1 2024+0.0%+0.8%+5.5%
Q4 2023+0.9%+0.6%-1.6%
Q3 2023-0.8%-1.1%+1.8%
Q2 2023-0.6%-0.2%+2.5%
Q1 2023+4.2%+3.9%+2.8%
Q4 2022+5.4%+2.2%-23.6%
Q3 2022-9.0%-4.2%-10.7%
Q2 2022-3.8%+0.9%-4.5%
Q1 2022+0.4%-3.3%-10.5%
Q4 2021+5.8%+14.5%+18.4%
Q3 2021+0.1%+1.7%-20.2%
Q2 2021-22.8%-22.9%-29.3%
Q1 2021+0.2%
Q4 2020-6.2%
Q3 2020-1.9%
Q2 2020+3.7%
Q1 2020-3.3%
Q4 2019-2.1%
Q3 2019-1.5%
Q2 2019-1.9%
Q1 2019-6.3%
Q4 2018+0.0%
Q3 2018+17.3%
Q2 2018+11.1%
Q1 2018+7.2%
Q4 2017+2.3%
Q3 2017+4.8%
Q2 2017-20.9%
Q1 2017+4.4%
Q4 2016+4.7%
Q3 2016-10.1%
Q2 2016-7.1%
Q1 2016-7.0%
Q4 2015+12.3%
Q3 2015+10.8%
Q2 2015-3.2%
Q1 2015+6.0%
Q4 2014-5.4%
Q3 2014+16.2%
Q2 2014+25.6%
Q1 2014-1.0%
Q4 2013-10.0%
Q3 2013-25.3%
Q2 2013+17.8%
Q1 2013-2.8%
Q4 2012-8.7%
Q3 2012-5.0%
Q2 2012+12.5%
Q1 2012-1.2%
Q4 2011-0.6%
Q3 2011-23.8%
Q2 2011-10.7%
Q1 2011-6.4%
Q4 2010-8.0%
Q3 2010+1.3%
Q2 2010-7.9%
Q1 2009-4.3%
Q1 2010+2.6%
Q4 2007-1.3%
Q4 2009-1.3%
Q3 2008-5.7%
Q3 2009-5.7%
Q4 2008+7.6%
Q2 2008+7.6%
Q2 2009+7.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro